nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—Cytochrome P450 3A Inhibitors—Crizotinib—lung cancer	0.747	1	CiPCiCtD
Darunavir—CYP3A4—Topotecan—lung cancer	0.02	0.142	CbGbCtD
Darunavir—CYP3A4—Gefitinib—lung cancer	0.0183	0.13	CbGbCtD
Darunavir—CYP3A4—Teniposide—lung cancer	0.0177	0.126	CbGbCtD
Darunavir—CYP3A4—Vinorelbine—lung cancer	0.0141	0.1	CbGbCtD
Darunavir—CYP3A4—Crizotinib—lung cancer	0.0112	0.0796	CbGbCtD
Darunavir—CYP3A4—Erlotinib—lung cancer	0.0108	0.0768	CbGbCtD
Darunavir—CYP3A4—Paclitaxel—lung cancer	0.00988	0.0703	CbGbCtD
Darunavir—CYP3A4—Irinotecan—lung cancer	0.00975	0.0694	CbGbCtD
Darunavir—CYP3A4—Vinblastine—lung cancer	0.00867	0.0617	CbGbCtD
Darunavir—CYP3A4—Etoposide—lung cancer	0.00781	0.0556	CbGbCtD
Darunavir—CYP3A4—Docetaxel—lung cancer	0.00715	0.0508	CbGbCtD
Darunavir—CYP3A4—Doxorubicin—lung cancer	0.00533	0.0379	CbGbCtD
Darunavir—CYP3A4—Felbamate Metabolism—CYP2E1—lung cancer	0.00021	0.0907	CbGpPWpGaD
Darunavir—Amprenavir—ABCB1—lung cancer	0.000109	1	CrCbGaD
Darunavir—CYP3A4—Codeine and Morphine Metabolism—ABCC3—lung cancer	0.000106	0.0459	CbGpPWpGaD
Darunavir—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—lung cancer	9.97e-05	0.0432	CbGpPWpGaD
Darunavir—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—lung cancer	9.35e-05	0.0405	CbGpPWpGaD
Darunavir—CYP3A4—Xenobiotics—CYP2A7—lung cancer	6.72e-05	0.0291	CbGpPWpGaD
Darunavir—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	6.37e-05	0.0276	CbGpPWpGaD
Darunavir—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	5.83e-05	0.0252	CbGpPWpGaD
Darunavir—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	5.8e-05	0.0251	CbGpPWpGaD
Darunavir—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	5.61e-05	0.0243	CbGpPWpGaD
Darunavir—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	5.53e-05	0.0239	CbGpPWpGaD
Darunavir—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	5.4e-05	0.0234	CbGpPWpGaD
Darunavir—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	5.21e-05	0.0226	CbGpPWpGaD
Darunavir—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	4.67e-05	0.0202	CbGpPWpGaD
Darunavir—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	4.52e-05	0.0196	CbGpPWpGaD
Darunavir—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	4.37e-05	0.0189	CbGpPWpGaD
Darunavir—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	3.97e-05	0.0172	CbGpPWpGaD
Darunavir—CYP3A4—Xenobiotics—CYP2A6—lung cancer	3.91e-05	0.0169	CbGpPWpGaD
Darunavir—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	3.76e-05	0.0163	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	3.67e-05	0.0159	CbGpPWpGaD
Darunavir—CYP3A4—Estrogen metabolism—NQO1—lung cancer	3.57e-05	0.0155	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	3.5e-05	0.0152	CbGpPWpGaD
Darunavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	3.33e-05	0.0144	CbGpPWpGaD
Darunavir—CYP3A4—Xenobiotics—CYP2E1—lung cancer	3.32e-05	0.0144	CbGpPWpGaD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	3.29e-05	0.0142	CbGpPWpGaD
Darunavir—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	3.19e-05	0.0138	CbGpPWpGaD
Darunavir—Asthenia—Irinotecan—lung cancer	3.14e-05	0.000287	CcSEcCtD
Darunavir—Fatigue—Etoposide—lung cancer	3.14e-05	0.000286	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	3.14e-05	0.000286	CcSEcCtD
Darunavir—Constipation—Etoposide—lung cancer	3.12e-05	0.000284	CcSEcCtD
Darunavir—Pain—Etoposide—lung cancer	3.12e-05	0.000284	CcSEcCtD
Darunavir—Neutropenia—Doxorubicin—lung cancer	3.11e-05	0.000283	CcSEcCtD
Darunavir—Dysuria—Doxorubicin—lung cancer	3.11e-05	0.000283	CcSEcCtD
Darunavir—Decreased appetite—Paclitaxel—lung cancer	3.11e-05	0.000283	CcSEcCtD
Darunavir—Dry mouth—Docetaxel—lung cancer	3.09e-05	0.000282	CcSEcCtD
Darunavir—Haemoglobin—Methotrexate—lung cancer	3.09e-05	0.000281	CcSEcCtD
Darunavir—Gastrointestinal disorder—Paclitaxel—lung cancer	3.09e-05	0.000281	CcSEcCtD
Darunavir—Fatigue—Paclitaxel—lung cancer	3.08e-05	0.000281	CcSEcCtD
Darunavir—Haemorrhage—Methotrexate—lung cancer	3.07e-05	0.00028	CcSEcCtD
Darunavir—Hepatitis—Methotrexate—lung cancer	3.07e-05	0.00028	CcSEcCtD
Darunavir—Pollakiuria—Doxorubicin—lung cancer	3.07e-05	0.00028	CcSEcCtD
Darunavir—Asthenia—Gemcitabine—lung cancer	3.06e-05	0.000279	CcSEcCtD
Darunavir—Pain—Paclitaxel—lung cancer	3.06e-05	0.000279	CcSEcCtD
Darunavir—Constipation—Paclitaxel—lung cancer	3.06e-05	0.000279	CcSEcCtD
Darunavir—Confusional state—Docetaxel—lung cancer	3.06e-05	0.000278	CcSEcCtD
Darunavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	3.05e-05	0.0132	CbGpPWpGaD
Darunavir—Urinary tract disorder—Methotrexate—lung cancer	3.04e-05	0.000277	CcSEcCtD
Darunavir—Weight increased—Doxorubicin—lung cancer	3.03e-05	0.000276	CcSEcCtD
Darunavir—Pruritus—Gemcitabine—lung cancer	3.02e-05	0.000275	CcSEcCtD
Darunavir—Urethral disorder—Methotrexate—lung cancer	3.01e-05	0.000275	CcSEcCtD
Darunavir—Weight decreased—Doxorubicin—lung cancer	3.01e-05	0.000274	CcSEcCtD
Darunavir—Feeling abnormal—Etoposide—lung cancer	3e-05	0.000274	CcSEcCtD
Darunavir—Hyperglycaemia—Doxorubicin—lung cancer	3e-05	0.000273	CcSEcCtD
Darunavir—Diarrhoea—Irinotecan—lung cancer	3e-05	0.000273	CcSEcCtD
Darunavir—Gastrointestinal pain—Etoposide—lung cancer	2.98e-05	0.000272	CcSEcCtD
Darunavir—Shock—Docetaxel—lung cancer	2.98e-05	0.000272	CcSEcCtD
Darunavir—Nervous system disorder—Docetaxel—lung cancer	2.97e-05	0.000271	CcSEcCtD
Darunavir—Thrombocytopenia—Docetaxel—lung cancer	2.97e-05	0.00027	CcSEcCtD
Darunavir—Infestation NOS—Doxorubicin—lung cancer	2.96e-05	0.00027	CcSEcCtD
Darunavir—Infestation—Doxorubicin—lung cancer	2.96e-05	0.00027	CcSEcCtD
Darunavir—Visual impairment—Methotrexate—lung cancer	2.96e-05	0.00027	CcSEcCtD
Darunavir—Tachycardia—Docetaxel—lung cancer	2.96e-05	0.000269	CcSEcCtD
Darunavir—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	2.95e-05	0.0128	CbGpPWpGaD
Darunavir—Feeling abnormal—Paclitaxel—lung cancer	2.95e-05	0.000268	CcSEcCtD
Darunavir—Skin disorder—Docetaxel—lung cancer	2.94e-05	0.000268	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Doxorubicin—lung cancer	2.94e-05	0.000268	CcSEcCtD
Darunavir—Hypersensitivity—Cisplatin—lung cancer	2.93e-05	0.000267	CcSEcCtD
Darunavir—Gastrointestinal pain—Paclitaxel—lung cancer	2.92e-05	0.000266	CcSEcCtD
Darunavir—Diarrhoea—Gemcitabine—lung cancer	2.92e-05	0.000266	CcSEcCtD
Darunavir—Renal failure—Doxorubicin—lung cancer	2.91e-05	0.000266	CcSEcCtD
Darunavir—Erythema multiforme—Methotrexate—lung cancer	2.91e-05	0.000265	CcSEcCtD
Darunavir—Neuropathy peripheral—Doxorubicin—lung cancer	2.91e-05	0.000265	CcSEcCtD
Darunavir—Dizziness—Irinotecan—lung cancer	2.9e-05	0.000264	CcSEcCtD
Darunavir—Urticaria—Etoposide—lung cancer	2.9e-05	0.000264	CcSEcCtD
Darunavir—Jaundice—Doxorubicin—lung cancer	2.89e-05	0.000263	CcSEcCtD
Darunavir—Stomatitis—Doxorubicin—lung cancer	2.89e-05	0.000263	CcSEcCtD
Darunavir—Anorexia—Docetaxel—lung cancer	2.89e-05	0.000263	CcSEcCtD
Darunavir—Abdominal pain—Etoposide—lung cancer	2.88e-05	0.000263	CcSEcCtD
Darunavir—Body temperature increased—Etoposide—lung cancer	2.88e-05	0.000263	CcSEcCtD
Darunavir—Eye disorder—Methotrexate—lung cancer	2.87e-05	0.000262	CcSEcCtD
Darunavir—Asthenia—Cisplatin—lung cancer	2.86e-05	0.00026	CcSEcCtD
Darunavir—Cardiac disorder—Methotrexate—lung cancer	2.85e-05	0.00026	CcSEcCtD
Darunavir—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	2.85e-05	0.0124	CbGpPWpGaD
Darunavir—Urticaria—Paclitaxel—lung cancer	2.84e-05	0.000259	CcSEcCtD
Darunavir—Haematuria—Doxorubicin—lung cancer	2.83e-05	0.000258	CcSEcCtD
Darunavir—Body temperature increased—Paclitaxel—lung cancer	2.83e-05	0.000257	CcSEcCtD
Darunavir—Abdominal pain—Paclitaxel—lung cancer	2.83e-05	0.000257	CcSEcCtD
Darunavir—Hepatobiliary disease—Doxorubicin—lung cancer	2.8e-05	0.000255	CcSEcCtD
Darunavir—Epistaxis—Doxorubicin—lung cancer	2.8e-05	0.000255	CcSEcCtD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	2.79e-05	0.0121	CbGpPWpGaD
Darunavir—Angiopathy—Methotrexate—lung cancer	2.79e-05	0.000254	CcSEcCtD
Darunavir—Vomiting—Irinotecan—lung cancer	2.79e-05	0.000254	CcSEcCtD
Darunavir—Immune system disorder—Methotrexate—lung cancer	2.78e-05	0.000253	CcSEcCtD
Darunavir—Mediastinal disorder—Methotrexate—lung cancer	2.77e-05	0.000252	CcSEcCtD
Darunavir—Rash—Irinotecan—lung cancer	2.76e-05	0.000252	CcSEcCtD
Darunavir—Dermatitis—Irinotecan—lung cancer	2.76e-05	0.000252	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Docetaxel—lung cancer	2.76e-05	0.000252	CcSEcCtD
Darunavir—Chills—Methotrexate—lung cancer	2.76e-05	0.000251	CcSEcCtD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	2.76e-05	0.0119	CbGpPWpGaD
Darunavir—Headache—Irinotecan—lung cancer	2.75e-05	0.00025	CcSEcCtD
Darunavir—Insomnia—Docetaxel—lung cancer	2.74e-05	0.00025	CcSEcCtD
Darunavir—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	2.74e-05	0.0119	CbGpPWpGaD
Darunavir—Diarrhoea—Cisplatin—lung cancer	2.72e-05	0.000248	CcSEcCtD
Darunavir—Paraesthesia—Docetaxel—lung cancer	2.72e-05	0.000248	CcSEcCtD
Darunavir—Alopecia—Methotrexate—lung cancer	2.72e-05	0.000247	CcSEcCtD
Darunavir—Vomiting—Gemcitabine—lung cancer	2.71e-05	0.000247	CcSEcCtD
Darunavir—Bradycardia—Doxorubicin—lung cancer	2.71e-05	0.000247	CcSEcCtD
Darunavir—Dyspnoea—Docetaxel—lung cancer	2.7e-05	0.000246	CcSEcCtD
Darunavir—Somnolence—Docetaxel—lung cancer	2.69e-05	0.000245	CcSEcCtD
Darunavir—Mental disorder—Methotrexate—lung cancer	2.69e-05	0.000245	CcSEcCtD
Darunavir—Rash—Gemcitabine—lung cancer	2.69e-05	0.000245	CcSEcCtD
Darunavir—Dermatitis—Gemcitabine—lung cancer	2.69e-05	0.000245	CcSEcCtD
Darunavir—Hypersensitivity—Etoposide—lung cancer	2.69e-05	0.000245	CcSEcCtD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	2.68e-05	0.0116	CbGpPWpGaD
Darunavir—Erythema—Methotrexate—lung cancer	2.68e-05	0.000244	CcSEcCtD
Darunavir—Malnutrition—Methotrexate—lung cancer	2.68e-05	0.000244	CcSEcCtD
Darunavir—Haemoglobin—Doxorubicin—lung cancer	2.68e-05	0.000244	CcSEcCtD
Darunavir—Headache—Gemcitabine—lung cancer	2.67e-05	0.000244	CcSEcCtD
Darunavir—Dyspepsia—Docetaxel—lung cancer	2.67e-05	0.000243	CcSEcCtD
Darunavir—Haemorrhage—Doxorubicin—lung cancer	2.66e-05	0.000243	CcSEcCtD
Darunavir—Hepatitis—Doxorubicin—lung cancer	2.66e-05	0.000243	CcSEcCtD
Darunavir—Hypoaesthesia—Doxorubicin—lung cancer	2.65e-05	0.000241	CcSEcCtD
Darunavir—Decreased appetite—Docetaxel—lung cancer	2.63e-05	0.00024	CcSEcCtD
Darunavir—Hypersensitivity—Paclitaxel—lung cancer	2.63e-05	0.00024	CcSEcCtD
Darunavir—Urinary tract disorder—Doxorubicin—lung cancer	2.63e-05	0.000239	CcSEcCtD
Darunavir—Oedema peripheral—Doxorubicin—lung cancer	2.62e-05	0.000239	CcSEcCtD
Darunavir—Dysgeusia—Methotrexate—lung cancer	2.62e-05	0.000239	CcSEcCtD
Darunavir—Gastrointestinal disorder—Docetaxel—lung cancer	2.62e-05	0.000238	CcSEcCtD
Darunavir—Asthenia—Etoposide—lung cancer	2.62e-05	0.000238	CcSEcCtD
Darunavir—Connective tissue disorder—Doxorubicin—lung cancer	2.62e-05	0.000238	CcSEcCtD
Darunavir—Fatigue—Docetaxel—lung cancer	2.61e-05	0.000238	CcSEcCtD
Darunavir—Urethral disorder—Doxorubicin—lung cancer	2.61e-05	0.000238	CcSEcCtD
Darunavir—Nausea—Irinotecan—lung cancer	2.6e-05	0.000237	CcSEcCtD
Darunavir—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	2.6e-05	0.0112	CbGpPWpGaD
Darunavir—Pain—Docetaxel—lung cancer	2.59e-05	0.000236	CcSEcCtD
Darunavir—Constipation—Docetaxel—lung cancer	2.59e-05	0.000236	CcSEcCtD
Darunavir—Pruritus—Etoposide—lung cancer	2.58e-05	0.000235	CcSEcCtD
Darunavir—Visual impairment—Doxorubicin—lung cancer	2.56e-05	0.000234	CcSEcCtD
Darunavir—Asthenia—Paclitaxel—lung cancer	2.56e-05	0.000234	CcSEcCtD
Darunavir—Nausea—Gemcitabine—lung cancer	2.54e-05	0.000231	CcSEcCtD
Darunavir—Vomiting—Cisplatin—lung cancer	2.53e-05	0.000231	CcSEcCtD
Darunavir—Pruritus—Paclitaxel—lung cancer	2.53e-05	0.00023	CcSEcCtD
Darunavir—Erythema multiforme—Doxorubicin—lung cancer	2.52e-05	0.000229	CcSEcCtD
Darunavir—Rash—Cisplatin—lung cancer	2.51e-05	0.000229	CcSEcCtD
Darunavir—Dermatitis—Cisplatin—lung cancer	2.51e-05	0.000228	CcSEcCtD
Darunavir—Feeling abnormal—Docetaxel—lung cancer	2.5e-05	0.000227	CcSEcCtD
Darunavir—Diarrhoea—Etoposide—lung cancer	2.49e-05	0.000227	CcSEcCtD
Darunavir—Eye disorder—Doxorubicin—lung cancer	2.49e-05	0.000227	CcSEcCtD
Darunavir—CYP3A4—Irinotecan Pathway—APC—lung cancer	2.49e-05	0.0108	CbGpPWpGaD
Darunavir—Ill-defined disorder—Methotrexate—lung cancer	2.48e-05	0.000226	CcSEcCtD
Darunavir—Gastrointestinal pain—Docetaxel—lung cancer	2.48e-05	0.000226	CcSEcCtD
Darunavir—Anaemia—Methotrexate—lung cancer	2.47e-05	0.000225	CcSEcCtD
Darunavir—Cardiac disorder—Doxorubicin—lung cancer	2.47e-05	0.000225	CcSEcCtD
Darunavir—Flushing—Doxorubicin—lung cancer	2.47e-05	0.000225	CcSEcCtD
Darunavir—Diarrhoea—Paclitaxel—lung cancer	2.45e-05	0.000223	CcSEcCtD
Darunavir—Angiopathy—Doxorubicin—lung cancer	2.41e-05	0.00022	CcSEcCtD
Darunavir—Malaise—Methotrexate—lung cancer	2.41e-05	0.00022	CcSEcCtD
Darunavir—Dizziness—Etoposide—lung cancer	2.41e-05	0.00022	CcSEcCtD
Darunavir—Immune system disorder—Doxorubicin—lung cancer	2.4e-05	0.000219	CcSEcCtD
Darunavir—Vertigo—Methotrexate—lung cancer	2.4e-05	0.000219	CcSEcCtD
Darunavir—Mediastinal disorder—Doxorubicin—lung cancer	2.4e-05	0.000219	CcSEcCtD
Darunavir—Abdominal pain—Docetaxel—lung cancer	2.4e-05	0.000218	CcSEcCtD
Darunavir—Body temperature increased—Docetaxel—lung cancer	2.4e-05	0.000218	CcSEcCtD
Darunavir—Leukopenia—Methotrexate—lung cancer	2.4e-05	0.000218	CcSEcCtD
Darunavir—Chills—Doxorubicin—lung cancer	2.39e-05	0.000218	CcSEcCtD
Darunavir—CYP3A4—Xenobiotics—CYP1A1—lung cancer	2.39e-05	0.0103	CbGpPWpGaD
Darunavir—Dizziness—Paclitaxel—lung cancer	2.36e-05	0.000215	CcSEcCtD
Darunavir—Nausea—Cisplatin—lung cancer	2.36e-05	0.000215	CcSEcCtD
Darunavir—Alopecia—Doxorubicin—lung cancer	2.35e-05	0.000214	CcSEcCtD
Darunavir—Cough—Methotrexate—lung cancer	2.33e-05	0.000213	CcSEcCtD
Darunavir—Mental disorder—Doxorubicin—lung cancer	2.33e-05	0.000212	CcSEcCtD
Darunavir—Convulsion—Methotrexate—lung cancer	2.32e-05	0.000211	CcSEcCtD
Darunavir—Vomiting—Etoposide—lung cancer	2.32e-05	0.000211	CcSEcCtD
Darunavir—Malnutrition—Doxorubicin—lung cancer	2.32e-05	0.000211	CcSEcCtD
Darunavir—Erythema—Doxorubicin—lung cancer	2.32e-05	0.000211	CcSEcCtD
Darunavir—Rash—Etoposide—lung cancer	2.3e-05	0.000209	CcSEcCtD
Darunavir—Dermatitis—Etoposide—lung cancer	2.3e-05	0.000209	CcSEcCtD
Darunavir—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	2.29e-05	0.00994	CbGpPWpGaD
Darunavir—Headache—Etoposide—lung cancer	2.28e-05	0.000208	CcSEcCtD
Darunavir—Flatulence—Doxorubicin—lung cancer	2.28e-05	0.000208	CcSEcCtD
Darunavir—Myalgia—Methotrexate—lung cancer	2.28e-05	0.000208	CcSEcCtD
Darunavir—Chest pain—Methotrexate—lung cancer	2.28e-05	0.000208	CcSEcCtD
Darunavir—Arthralgia—Methotrexate—lung cancer	2.28e-05	0.000208	CcSEcCtD
Darunavir—Vomiting—Paclitaxel—lung cancer	2.27e-05	0.000207	CcSEcCtD
Darunavir—Dysgeusia—Doxorubicin—lung cancer	2.27e-05	0.000207	CcSEcCtD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	2.26e-05	0.0098	CbGpPWpGaD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.26e-05	0.000206	CcSEcCtD
Darunavir—Rash—Paclitaxel—lung cancer	2.25e-05	0.000205	CcSEcCtD
Darunavir—Dermatitis—Paclitaxel—lung cancer	2.25e-05	0.000205	CcSEcCtD
Darunavir—Discomfort—Methotrexate—lung cancer	2.25e-05	0.000205	CcSEcCtD
Darunavir—Headache—Paclitaxel—lung cancer	2.24e-05	0.000204	CcSEcCtD
Darunavir—Hypersensitivity—Docetaxel—lung cancer	2.23e-05	0.000203	CcSEcCtD
Darunavir—Muscle spasms—Doxorubicin—lung cancer	2.23e-05	0.000203	CcSEcCtD
Darunavir—Confusional state—Methotrexate—lung cancer	2.2e-05	0.000201	CcSEcCtD
Darunavir—Asthenia—Docetaxel—lung cancer	2.17e-05	0.000198	CcSEcCtD
Darunavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	2.17e-05	0.00941	CbGpPWpGaD
Darunavir—Nausea—Etoposide—lung cancer	2.17e-05	0.000197	CcSEcCtD
Darunavir—Ill-defined disorder—Doxorubicin—lung cancer	2.15e-05	0.000196	CcSEcCtD
Darunavir—Pruritus—Docetaxel—lung cancer	2.14e-05	0.000195	CcSEcCtD
Darunavir—Nervous system disorder—Methotrexate—lung cancer	2.14e-05	0.000195	CcSEcCtD
Darunavir—Anaemia—Doxorubicin—lung cancer	2.14e-05	0.000195	CcSEcCtD
Darunavir—Thrombocytopenia—Methotrexate—lung cancer	2.14e-05	0.000195	CcSEcCtD
Darunavir—Agitation—Doxorubicin—lung cancer	2.13e-05	0.000194	CcSEcCtD
Darunavir—Nausea—Paclitaxel—lung cancer	2.12e-05	0.000193	CcSEcCtD
Darunavir—Skin disorder—Methotrexate—lung cancer	2.12e-05	0.000193	CcSEcCtD
Darunavir—Hyperhidrosis—Methotrexate—lung cancer	2.11e-05	0.000192	CcSEcCtD
Darunavir—Malaise—Doxorubicin—lung cancer	2.09e-05	0.00019	CcSEcCtD
Darunavir—Vertigo—Doxorubicin—lung cancer	2.08e-05	0.00019	CcSEcCtD
Darunavir—Anorexia—Methotrexate—lung cancer	2.08e-05	0.00019	CcSEcCtD
Darunavir—Syncope—Doxorubicin—lung cancer	2.08e-05	0.000189	CcSEcCtD
Darunavir—Leukopenia—Doxorubicin—lung cancer	2.07e-05	0.000189	CcSEcCtD
Darunavir—Diarrhoea—Docetaxel—lung cancer	2.07e-05	0.000189	CcSEcCtD
Darunavir—Palpitations—Doxorubicin—lung cancer	2.05e-05	0.000187	CcSEcCtD
Darunavir—Loss of consciousness—Doxorubicin—lung cancer	2.04e-05	0.000186	CcSEcCtD
Darunavir—Cough—Doxorubicin—lung cancer	2.02e-05	0.000184	CcSEcCtD
Darunavir—Convulsion—Doxorubicin—lung cancer	2.01e-05	0.000183	CcSEcCtD
Darunavir—Dizziness—Docetaxel—lung cancer	2e-05	0.000183	CcSEcCtD
Darunavir—Hypertension—Doxorubicin—lung cancer	2e-05	0.000182	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Methotrexate—lung cancer	1.99e-05	0.000181	CcSEcCtD
Darunavir—Insomnia—Methotrexate—lung cancer	1.98e-05	0.00018	CcSEcCtD
Darunavir—Chest pain—Doxorubicin—lung cancer	1.97e-05	0.00018	CcSEcCtD
Darunavir—Arthralgia—Doxorubicin—lung cancer	1.97e-05	0.00018	CcSEcCtD
Darunavir—Myalgia—Doxorubicin—lung cancer	1.97e-05	0.00018	CcSEcCtD
Darunavir—Anxiety—Doxorubicin—lung cancer	1.97e-05	0.000179	CcSEcCtD
Darunavir—Paraesthesia—Methotrexate—lung cancer	1.96e-05	0.000179	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	1.96e-05	0.000178	CcSEcCtD
Darunavir—Discomfort—Doxorubicin—lung cancer	1.95e-05	0.000178	CcSEcCtD
Darunavir—Dyspnoea—Methotrexate—lung cancer	1.95e-05	0.000177	CcSEcCtD
Darunavir—Somnolence—Methotrexate—lung cancer	1.94e-05	0.000177	CcSEcCtD
Darunavir—Dry mouth—Doxorubicin—lung cancer	1.93e-05	0.000176	CcSEcCtD
Darunavir—Vomiting—Docetaxel—lung cancer	1.93e-05	0.000176	CcSEcCtD
Darunavir—Dyspepsia—Methotrexate—lung cancer	1.92e-05	0.000175	CcSEcCtD
Darunavir—Rash—Docetaxel—lung cancer	1.91e-05	0.000174	CcSEcCtD
Darunavir—Dermatitis—Docetaxel—lung cancer	1.91e-05	0.000174	CcSEcCtD
Darunavir—Confusional state—Doxorubicin—lung cancer	1.91e-05	0.000174	CcSEcCtD
Darunavir—Decreased appetite—Methotrexate—lung cancer	1.9e-05	0.000173	CcSEcCtD
Darunavir—Headache—Docetaxel—lung cancer	1.9e-05	0.000173	CcSEcCtD
Darunavir—Gastrointestinal disorder—Methotrexate—lung cancer	1.89e-05	0.000172	CcSEcCtD
Darunavir—Fatigue—Methotrexate—lung cancer	1.88e-05	0.000172	CcSEcCtD
Darunavir—Pain—Methotrexate—lung cancer	1.87e-05	0.00017	CcSEcCtD
Darunavir—Shock—Doxorubicin—lung cancer	1.86e-05	0.00017	CcSEcCtD
Darunavir—Nervous system disorder—Doxorubicin—lung cancer	1.85e-05	0.000169	CcSEcCtD
Darunavir—Thrombocytopenia—Doxorubicin—lung cancer	1.85e-05	0.000169	CcSEcCtD
Darunavir—Tachycardia—Doxorubicin—lung cancer	1.85e-05	0.000168	CcSEcCtD
Darunavir—Skin disorder—Doxorubicin—lung cancer	1.84e-05	0.000167	CcSEcCtD
Darunavir—Hyperhidrosis—Doxorubicin—lung cancer	1.83e-05	0.000167	CcSEcCtD
Darunavir—Anorexia—Doxorubicin—lung cancer	1.8e-05	0.000164	CcSEcCtD
Darunavir—Nausea—Docetaxel—lung cancer	1.8e-05	0.000164	CcSEcCtD
Darunavir—Feeling abnormal—Methotrexate—lung cancer	1.8e-05	0.000164	CcSEcCtD
Darunavir—Gastrointestinal pain—Methotrexate—lung cancer	1.79e-05	0.000163	CcSEcCtD
Darunavir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	1.78e-05	0.00771	CbGpPWpGaD
Darunavir—Urticaria—Methotrexate—lung cancer	1.73e-05	0.000158	CcSEcCtD
Darunavir—Body temperature increased—Methotrexate—lung cancer	1.73e-05	0.000157	CcSEcCtD
Darunavir—Abdominal pain—Methotrexate—lung cancer	1.73e-05	0.000157	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.72e-05	0.000157	CcSEcCtD
Darunavir—Insomnia—Doxorubicin—lung cancer	1.71e-05	0.000156	CcSEcCtD
Darunavir—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	1.71e-05	0.00739	CbGpPWpGaD
Darunavir—Paraesthesia—Doxorubicin—lung cancer	1.7e-05	0.000155	CcSEcCtD
Darunavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	1.7e-05	0.00734	CbGpPWpGaD
Darunavir—Dyspnoea—Doxorubicin—lung cancer	1.69e-05	0.000154	CcSEcCtD
Darunavir—Somnolence—Doxorubicin—lung cancer	1.68e-05	0.000153	CcSEcCtD
Darunavir—Dyspepsia—Doxorubicin—lung cancer	1.66e-05	0.000152	CcSEcCtD
Darunavir—Decreased appetite—Doxorubicin—lung cancer	1.64e-05	0.00015	CcSEcCtD
Darunavir—Gastrointestinal disorder—Doxorubicin—lung cancer	1.63e-05	0.000149	CcSEcCtD
Darunavir—Fatigue—Doxorubicin—lung cancer	1.63e-05	0.000149	CcSEcCtD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	1.62e-05	0.00702	CbGpPWpGaD
Darunavir—Constipation—Doxorubicin—lung cancer	1.62e-05	0.000147	CcSEcCtD
Darunavir—Pain—Doxorubicin—lung cancer	1.62e-05	0.000147	CcSEcCtD
Darunavir—Hypersensitivity—Methotrexate—lung cancer	1.61e-05	0.000147	CcSEcCtD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	1.6e-05	0.00693	CbGpPWpGaD
Darunavir—Asthenia—Methotrexate—lung cancer	1.57e-05	0.000143	CcSEcCtD
Darunavir—Feeling abnormal—Doxorubicin—lung cancer	1.56e-05	0.000142	CcSEcCtD
Darunavir—Gastrointestinal pain—Doxorubicin—lung cancer	1.55e-05	0.000141	CcSEcCtD
Darunavir—Pruritus—Methotrexate—lung cancer	1.55e-05	0.000141	CcSEcCtD
Darunavir—Urticaria—Doxorubicin—lung cancer	1.5e-05	0.000137	CcSEcCtD
Darunavir—Body temperature increased—Doxorubicin—lung cancer	1.49e-05	0.000136	CcSEcCtD
Darunavir—Abdominal pain—Doxorubicin—lung cancer	1.49e-05	0.000136	CcSEcCtD
Darunavir—Diarrhoea—Methotrexate—lung cancer	1.49e-05	0.000136	CcSEcCtD
Darunavir—Dizziness—Methotrexate—lung cancer	1.44e-05	0.000132	CcSEcCtD
Darunavir—Hypersensitivity—Doxorubicin—lung cancer	1.39e-05	0.000127	CcSEcCtD
Darunavir—Vomiting—Methotrexate—lung cancer	1.39e-05	0.000127	CcSEcCtD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	1.38e-05	0.00597	CbGpPWpGaD
Darunavir—Rash—Methotrexate—lung cancer	1.38e-05	0.000125	CcSEcCtD
Darunavir—Dermatitis—Methotrexate—lung cancer	1.38e-05	0.000125	CcSEcCtD
Darunavir—CYP3A4—Tryptophan metabolism—CAT—lung cancer	1.37e-05	0.00593	CbGpPWpGaD
Darunavir—Headache—Methotrexate—lung cancer	1.37e-05	0.000125	CcSEcCtD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	1.36e-05	0.00589	CbGpPWpGaD
Darunavir—Asthenia—Doxorubicin—lung cancer	1.36e-05	0.000124	CcSEcCtD
Darunavir—Pruritus—Doxorubicin—lung cancer	1.34e-05	0.000122	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—GSTM2—lung cancer	1.33e-05	0.00576	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—CNDP2—lung cancer	1.33e-05	0.00576	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	1.31e-05	0.00569	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	1.31e-05	0.00568	CbGpPWpGaD
Darunavir—Nausea—Methotrexate—lung cancer	1.3e-05	0.000118	CcSEcCtD
Darunavir—Diarrhoea—Doxorubicin—lung cancer	1.29e-05	0.000118	CcSEcCtD
Darunavir—Dizziness—Doxorubicin—lung cancer	1.25e-05	0.000114	CcSEcCtD
Darunavir—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	1.23e-05	0.00531	CbGpPWpGaD
Darunavir—Vomiting—Doxorubicin—lung cancer	1.2e-05	0.00011	CcSEcCtD
Darunavir—CYP3A4—Biological oxidations—CYP2A7—lung cancer	1.2e-05	0.00521	CbGpPWpGaD
Darunavir—Rash—Doxorubicin—lung cancer	1.19e-05	0.000109	CcSEcCtD
Darunavir—Dermatitis—Doxorubicin—lung cancer	1.19e-05	0.000109	CcSEcCtD
Darunavir—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	1.19e-05	0.00514	CbGpPWpGaD
Darunavir—Headache—Doxorubicin—lung cancer	1.18e-05	0.000108	CcSEcCtD
Darunavir—Nausea—Doxorubicin—lung cancer	1.12e-05	0.000102	CcSEcCtD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	1.12e-05	0.00484	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTA3—lung cancer	1.07e-05	0.00464	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	1.06e-05	0.00458	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	9.91e-06	0.00429	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTA4—lung cancer	9.8e-06	0.00424	CbGpPWpGaD
Darunavir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	9.78e-06	0.00423	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	9.67e-06	0.00419	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTA2—lung cancer	9.55e-06	0.00414	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTA1—lung cancer	9.21e-06	0.00399	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	8.7e-06	0.00377	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—UGT1A1—lung cancer	8.57e-06	0.00371	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	8.45e-06	0.00366	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	8.03e-06	0.00348	CbGpPWpGaD
Darunavir—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	7.56e-06	0.00327	CbGpPWpGaD
Darunavir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	7.39e-06	0.0032	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—HPGDS—lung cancer	7.28e-06	0.00315	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTT1—lung cancer	7.06e-06	0.00306	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GCLC—lung cancer	6.98e-06	0.00302	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—CYP2A6—lung cancer	6.98e-06	0.00302	CbGpPWpGaD
Darunavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	5.99e-06	0.00259	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—CYP2E1—lung cancer	5.94e-06	0.00257	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	5.86e-06	0.00254	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTP1—lung cancer	4.9e-06	0.00212	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	4.83e-06	0.00209	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—GSTM1—lung cancer	4.5e-06	0.00195	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	4.44e-06	0.00192	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—CYP1A1—lung cancer	4.27e-06	0.00185	CbGpPWpGaD
Darunavir—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	4.21e-06	0.00182	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—COL4A3BP—lung cancer	3.75e-06	0.00163	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—AZIN2—lung cancer	3.75e-06	0.00163	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ATP5H—lung cancer	3.19e-06	0.00138	CbGpPWpGaD
Darunavir—CYP3A4—Biological oxidations—POMC—lung cancer	3.18e-06	0.00138	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PLBD1—lung cancer	2.84e-06	0.00123	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—HSD17B10—lung cancer	2.6e-06	0.00113	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CKB—lung cancer	2.42e-06	0.00105	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTM2—lung cancer	2.27e-06	0.000985	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CNDP2—lung cancer	2.27e-06	0.000985	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—MTMR3—lung cancer	2.21e-06	0.000958	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PGAM1—lung cancer	2.16e-06	0.000933	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP2A7—lung cancer	2.06e-06	0.00089	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—SDC4—lung cancer	2.01e-06	0.000871	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTA3—lung cancer	1.83e-06	0.000794	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—RRM1—lung cancer	1.83e-06	0.000794	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—B4GALT5—lung cancer	1.72e-06	0.000746	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTA4—lung cancer	1.68e-06	0.000726	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTA2—lung cancer	1.63e-06	0.000707	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTA1—lung cancer	1.58e-06	0.000682	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ABCC3—lung cancer	1.56e-06	0.000675	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—AKR1C1—lung cancer	1.51e-06	0.000654	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—UGT1A1—lung cancer	1.47e-06	0.000634	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GNG11—lung cancer	1.41e-06	0.000612	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ALDOA—lung cancer	1.35e-06	0.000582	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—NCOA3—lung cancer	1.31e-06	0.000565	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ADCY1—lung cancer	1.27e-06	0.00055	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ABCG2—lung cancer	1.27e-06	0.00055	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ENO2—lung cancer	1.25e-06	0.000539	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—HPGDS—lung cancer	1.25e-06	0.000539	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.24e-06	0.000536	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTT1—lung cancer	1.21e-06	0.000523	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GCLC—lung cancer	1.19e-06	0.000517	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP2A6—lung cancer	1.19e-06	0.000517	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ENO1—lung cancer	1.13e-06	0.00049	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP2E1—lung cancer	1.02e-06	0.00044	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—NQO1—lung cancer	1e-06	0.000435	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—STK11—lung cancer	9.05e-07	0.000392	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTP1—lung cancer	8.37e-07	0.000363	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CAT—lung cancer	8.15e-07	0.000353	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ABCB1—lung cancer	7.93e-07	0.000343	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—TYMS—lung cancer	7.79e-07	0.000337	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—GSTM1—lung cancer	7.7e-07	0.000333	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CYP1A1—lung cancer	7.3e-07	0.000316	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ERCC2—lung cancer	7.24e-07	0.000313	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—APOA1—lung cancer	6.26e-07	0.000271	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PIK3CG—lung cancer	5.71e-07	0.000247	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—POMC—lung cancer	5.44e-07	0.000236	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—CREBBP—lung cancer	5.3e-07	0.000229	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PIK3CD—lung cancer	5.02e-07	0.000218	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—ALB—lung cancer	4.96e-07	0.000215	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PIK3CB—lung cancer	4.38e-07	0.00019	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PTGS2—lung cancer	4.34e-07	0.000188	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PTEN—lung cancer	3.78e-07	0.000164	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—EP300—lung cancer	3.61e-07	0.000156	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—PIK3CA—lung cancer	2.67e-07	0.000116	CbGpPWpGaD
Darunavir—CYP3A4—Metabolism—AKT1—lung cancer	2.18e-07	9.44e-05	CbGpPWpGaD
